Telomir Pharmaceuticals (TELO) Prepaid Assets (2023 - 2026)
Telomir Pharmaceuticals (TELO) posted Prepaid Assets of $54691.0 for Q4 2025, down 24.89% sequentially from $72819.0 in Q3 2025, and down 5.5% YoY from $57874.0 in Q4 2024.
Telomir Pharmaceuticals (TELO) Prepaid Assets (2023 - 2026) Analysis & Trends
Telomir Pharmaceuticals has reported Prepaid Assets for 3 years, with the latest figure at $54691.0 in Q4 2025.
- Quarterly Prepaid Assets fell 5.5% year-over-year to $54691.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54691.0 (down 5.5% YoY) and the FY2025 annual result came in at $54691.0, down 5.5% from the prior year.
- Prepaid Assets declined to $54691.0 in Q4 2025 per TELO's latest filing, from $72819.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $98808.0 in Q1 2024 and troughed at $713.0 in Q4 2023.
- A 3-year average of $68171.3 and a median of $75288.0 in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets soared 8016.97% in 2024, then declined 14.26% in 2025.
- Over 3 years, Prepaid Assets stood at $713.0 in 2023, then jumped by 8016.97% to $57874.0 in 2024, then declined by 5.5% to $54691.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $54691.0, $72819.0, and $75288.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Telomir Pharmaceuticals | 69.05 Mn | 69.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 195,618.00 |
| Dec 31, 2025 | 54,691.00 |
| Sep 30, 2025 | 72,819.00 |
| Jun 30, 2025 | 75,288.00 |
| Mar 31, 2025 | 88,189.00 |
| Dec 31, 2024 | 57,874.00 |
| Sep 30, 2024 | 77,347.00 |
| Jun 30, 2024 | 87,813.00 |
| Mar 31, 2024 | 98,808.00 |
| Dec 31, 2023 | 713.00 |